Literature DB >> 3106411

Density profile of group B streptococci, type III, and its possible relation to enhanced virulence.

S Håkansson, S E Holm, M Wagner.   

Abstract

The buoyant densities of virulent and colonizing group B streptococci, type III, were determined by centrifugation of bacteria on a linear, hypotonic density gradient. A total of 28 strains were investigated. Eleven strains were obtained from blood cultures of babies with early-onset disease, and eight strains were isolated from the cerebrospinal fluid of babies with late-onset septicemia and meningitis. Nine colonizing strains were genital isolates from pregnant women subsequently giving birth to healthy children. In each strain the buoyant density was determined before and after neuraminidase treatment. All strains showed an increase in the buoyant density after enzymatic removal of sialic acid, and the density differences before and after desialylation were calculated. The mean values of these differences for blood, cerebrospinal fluid, and colonizing isolates were 23.4, 25.3, and 10.6 mg/ml, respectively. The mean value for the colonizing strains differed significantly from the mean value for each group of virulent strains. All colonizing strains banded singly in the gradient, whereas five of the virulent strains divided into two density populations. Extracts of the low-density cells produced markedly more dense immunoprecipitates with type antiserum than did extracts of the high-density bacteria. One double-banding strain was positive for R protein. After separation of the two density populations, this antigen was detected only in the low-density population. The results indicate that bacterial buoyant density is inversely related to the amount of capsular polysaccharide enveloping the cell and that a determination of the density profile of the bacteria may be used for discriminating strains with an increased pathogenic potential.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106411      PMCID: PMC266065          DOI: 10.1128/jcm.25.4.714-718.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  COMPARATIVE TESTING OF A NEW PHOTOGRAPHIC MATERIAL FOR RAPID REGISTRATION OF IMMUNOPRECIPITATES.

Authors:  C WADSWORTH
Journal:  Int Arch Allergy Appl Immunol       Date:  1963

2.  Bacterial capsule--old dogmas and new tricks.

Authors:  D L Kasper
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

3.  Selective broth medium for isolation of group B streptococci.

Authors:  C J Baker; D J Clark; F F Barrett
Journal:  Appl Microbiol       Date:  1973-12

4.  Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci.

Authors:  M K Yeung; S J Mattingly
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

5.  Assessment of the virulence factors of group B streptococci: correlation with sialic acid content.

Authors:  A O Shigeoka; N S Rote; J I Santos; H R Hill
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

6.  Strain differences in virulence of group B streptococci.

Authors:  J I Santos; A O Shigeoka; H R Hill
Journal:  Pediatr Res       Date:  1982-05       Impact factor: 3.756

7.  Influence of polysaccaride capsule and ionic strength on buoyant density of group B streptococci.

Authors:  S Håkansson; S Holm
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1986-06

8.  Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide.

Authors:  H J Jennings; C Lugowski; D L Kasper
Journal:  Biochemistry       Date:  1981-08-04       Impact factor: 3.162

9.  Immunoelectron microscopic study of the location of group-specific and type-specific polysaccharide antigens on isolated walls of group B streptococci.

Authors:  M Wagner; B Wagner; V R Kubín
Journal:  J Gen Microbiol       Date:  1980-10

10.  Kinetic and chemical analyses of the biologic significance of lipoteichoic acids in mediating adherence of serotype III group B streptococci.

Authors:  T J Nealon; S J Mattingly
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

View more
  8 in total

1.  Differential expression of Vibrio vulnificus capsular polysaccharide.

Authors:  A C Wright; J L Powell; M K Tanner; L A Ensor; A B Karpas; J G Morris; M B Sztein
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Novel coagglutination method for serotyping group B streptococci.

Authors:  S Håkansson; L G Burman; J Henrichsen; S E Holm
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

3.  Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae.

Authors:  D E Briles; M J Crain; B M Gray; C Forman; J Yother
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

4.  Large-scale screen highlights the importance of capsule for virulence in the zoonotic pathogen Streptococcus iniae.

Authors:  Jesse D Miller; Melody N Neely
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

5.  Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae.

Authors:  D E Briles; C Forman; M Crain
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

6.  Activity of polymorphonuclear leukocytes in the presence of sulfide.

Authors:  R Claesson; M Granlund-Edstedt; S Persson; J Carlsson
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

7.  Genetic and biochemical modulation of sialic acid O-acetylation on group B Streptococcus: phenotypic and functional impact.

Authors:  Shannon Weiman; Samira Dahesh; Aaron F Carlin; Ajit Varki; Victor Nizet; Amanda L Lewis
Journal:  Glycobiology       Date:  2009-07-30       Impact factor: 4.313

8.  Both group 4 capsule and lipopolysaccharide O-antigen contribute to enteropathogenic Escherichia coli resistance to human α-defensin 5.

Authors:  Jenny-Lee Thomassin; Mark J Lee; John R Brannon; Donald C Sheppard; Samantha Gruenheid; Hervé Le Moual
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.